Williamson K. International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease. PS-134.
Vroege behandeling van milde tot matige COVID-19 met sotrovimab reduceert risico op progressie
apr 2022 | Pneumonie, Virale infecties